You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CYNK-001-COVID-19

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Real-World Study of JT001 for COVID-19

Recruiting
  • COVID-19
  • Beijing, Beijing, China
  • +5 more
Nov 20, 2023

Post-Acute COVID-19 Syndrome, Cognitive Impairment, Neurological Complication Trial (VIX001)

Not yet recruiting
  • Post-Acute COVID-19 Syndrome
  • +2 more
  • (no location specified)
Jul 14, 2023

Covid19, Acute Respiratory Distress Syndrome Trial in Australia (CYP-001)

Completed
  • Covid19
  • Acute Respiratory Distress Syndrome
  • CYP-001
  • Kingswood, New South Wales, Australia
  • +4 more
Nov 28, 2022

COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)

Active, not recruiting
  • COVID-19
  • Vaccine Reaction
  • LYB001
  • CoronaVac
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023

COVID-19 Trial (LYB001, Placebo)

Not yet recruiting
  • COVID-19
  • LYB001
  • Placebo
  • (no location specified)
Oct 26, 2022

COVID-19 Trial in Nanjing (low-dose LYB001, Recombinant COVID-19 Vaccine (CHO Cell), high-dose LYB001)

Active, not recruiting
  • COVID-19
  • low-dose LYB001
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Dec 25, 2022

COVID-19 Trial in Wuhan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, ZF2001)

Active, not recruiting
  • COVID-19
  • Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
  • ZF2001
  • Wuhan, Hubei, China
    Hubei Provincial Center for Disease Control and Prevention
Jan 12, 2023

Mild to Moderate COVID-19 Trial in China (JT001, Placebo)

Recruiting
  • Mild to Moderate COVID-19
  • Fuzhou, Fujian, China
  • +8 more
Nov 17, 2022

COVID-19 Trial in Germany, Switzerland (KIN001, KIN001-Placebo)

Recruiting
  • COVID-19
  • Cologne, Germany
  • +7 more
Dec 12, 2022

COVID-19 Trial in Shanghai (JT001, Paxlovid)

Completed
  • COVID-19
  • Shanghai, Shanghai, China
  • +6 more
Sep 18, 2022

Acute Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome in Adult or Child, COVID-19 Pneumonia Trial in Las

Recruiting
  • Acute Respiratory Distress Syndrome
  • +5 more
  • AV-001 Injection
  • AV-001 Placebo Injection
  • Las Vegas, Nevada
    University Medical Center of Southern Nevada
Nov 28, 2022

COVID-19, ARDS, Acute Respiratory Distress Syndrome Trial (Human umbilical cord mesenchymal stem cells + best supportive care,

Not yet recruiting
  • COVID-19
  • +2 more
  • Human umbilical cord mesenchymal stem cells + best supportive care
  • Placebo control + best supportive care
  • (no location specified)
Aug 9, 2022

COVID-19, ARDS, Human, Stem Cells Trial in Baltimore (MRG-001, Placebo)

Recruiting
  • COVID-19
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins Medicine
Jan 30, 2022

COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)

Recruiting
  • COVID-19
  • +3 more
  • RQ-001
  • Placebo
  • Cullman, Alabama
  • +8 more
Sep 28, 2023

COVID-19 Trial in Nanjing (One dose group, Two doses group, Aged 18-59 years)

Not yet recruiting
  • COVID-19
  • One dose group
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Dec 25, 2022

COVID-19 Trial in Natal, São Paulo (SCB-2019/Clover, AstraZeneca/Fiocruz, Pfizer/Wyeth)

Active, not recruiting
  • COVID-19
  • SCB-2019/Clover
  • +2 more
  • Natal, Rio Grande Do Norte, Brazil
  • +1 more
Apr 10, 2023

Mild to Moderate COVID-19 Trial in China, Hong Kong (JT001, Placebo)

Recruiting
  • Mild to Moderate COVID-19
  • Chongqing, Chongqing, China
  • +7 more
Apr 4, 2022

Moderate to Severe COVID-19 Trial in Shanghai, Tashkent (JT001, JT001 , Favipiravir)

Not yet recruiting
  • Moderate to Severe COVID-19
  • Shanghai, Shanghai, China
  • +1 more
Mar 14, 2022

COVID-19 Trial in New York (AT-001)

Completed
Has Results
  • COVID-19
  • New York, New York
    NYU Langone Health
Sep 10, 2021

Infectious Disease, COVID-19 Trial in Singapore (RVM-V001 30 µg, RVM-V002 30 µg, RVM-V001 (15 µg) + RVM-V002 (15 µg)

Recruiting
  • Infectious Disease
  • COVID-19
  • RVM-V001 30 µg
  • +2 more
  • Singapore, Singapore
    P.H. Feng Research Centre, NCID,TTSH
Mar 27, 2023

Covid19 Trial in Liege (Drug, inhalation)

Recruiting
  • Covid19
  • Drug, inhalation
  • Liege, Belgium
    CHU Liege
Feb 14, 2022

COVID-19 Pneumonia Trial in Worldwide (BDB-001 Injection, Conventional treatment)

Unknown status
  • COVID-19 Pneumonia
  • BDB-001 Injection
  • Conventional treatment
  • Dhaka, Bangladesh
  • +11 more
Dec 29, 2021

COVID-19 Trial in United States (Niclosamide, Placebo)

Recruiting
  • COVID-19
  • Sheffield, Alabama
  • +8 more
Apr 22, 2022

COVID-19 Trial in Sanya, Wuhan, Hangzhou (BDB-001 injection)

Completed
  • COVID-19
  • BDB-001 injection
  • Sanya, Hainan, China
  • +3 more
Oct 8, 2021

COVID-19 Trial in Chongqing, Jinan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, Placebo)

Active, not recruiting
  • COVID-19
  • Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
  • Placebo
  • Chongqing, Chongqing, China
  • +1 more
Jan 11, 2023